EMS and Torrent Pharma are top contenders for Sanofi's generics unit

Feb 06, 2018

The Brazilian EMS and Indian rival Torrent Pharma have emerged as the two leading bidders for Sanofi’s generic drugs unit that according to Reuters reports is valued for as much as $2.4 billion. The two companies submitted indicative bids in January.

Talks of Sanofi selling the unit were first heard in late 2015, with sources saying that Sanofi is finally aiming to find a buyer by the end of the first quarter of this year.

Sanofi's generic drugs portfolio includes cardiovascular and gastrointestinal drugs as well as painkillers and anti-inflammatory drugs based on ibuprofen and leflunomide molecules.

Read the Reuters report